Search research articles
Contact Us
Filters
Showing results (61-70 of 101) with videos related to
Page
of 11
Sort By:
Journal for Immunotherapy of Cancer
|
June 24, 2020
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
Yasser Ged, Joshua L Chaim, Renzo G DiNatale, et al.
The Lancet. Oncology
|
July 14, 2023
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Laurence Albiges, Howard Gurney, Vagif Atduev, et al.
JCO Precision Oncology
|
September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets
Maria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
European Urology
|
October 19, 2024
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94]
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
European Urology
|
May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
Yasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Cancer
|
October 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
Ritesh R Kotecha, Andrea Knezevic, Kanika Arora, et al.
Urologic Oncology
|
December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
Stephen W Reese, Lennert Eismann, Charlie White, et al.
European Urology
|
August 6, 2020
Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
Min Yuen Teo, Jose Mauricio Mota, Karissa A Whiting, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 101) with videos related to
Sort By:
Page
of 11
Journal for Immunotherapy of Cancer
|
June 24, 2020
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
Yasser Ged, Joshua L Chaim, Renzo G DiNatale, et al.
The Lancet. Oncology
|
July 14, 2023
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial
Laurence Albiges, Howard Gurney, Vagif Atduev, et al.
JCO Precision Oncology
|
September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets
Maria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
European Urology
|
October 19, 2024
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94]
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
European Urology
|
May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
Kelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
Yasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Cancer
|
October 21, 2023
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features
Ritesh R Kotecha, Andrea Knezevic, Kanika Arora, et al.
Urologic Oncology
|
December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
Stephen W Reese, Lennert Eismann, Charlie White, et al.
European Urology
|
August 6, 2020
Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
Min Yuen Teo, Jose Mauricio Mota, Karissa A Whiting, et al.
European Urology Oncology
|
November 9, 2023
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
Ritesh R Kotecha, Sahil D Doshi, Andrea Knezevic, et al.
Page
of 11